Sign inJoin waitlistJoin the waitlist

Yuhchyau Chen

Chair · University of Rochester Medicine

Credentials: · · · ·

History

University of Rochester Medicine
Present
University of Rochester Medicine
Present

Harvard Medical School.
1995–1996
Radiation Oncology
Massachusetts General Hospital.
1991–1995
Virginia Mason Medical Center.
1990–1991
University of Washington School of Medicine
1986–1990

Research

Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial
The Lancet · 2009 · 1,153 citations
Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate Cancer
Journal of Clinical Oncology · 2016 · 523 citations
Radiation pneumonitis and early circulatory cytokine markers
Seminars in Radiation Oncology · 2002 · First of 9 authors · 193 citations

Paul Okunieff
18 papers
Michael Milano
17 papers
Deepinder Singh
11 papers · 2 as a resident
Hong Zhang
9 papers
Jeff Michalski
9 papers
HS
Howard Sandler
7 papers
KP
Kishan Pandya
7 papers
SS
Samantha Seaward
7 papers
TP
Thomas Pisansky
6 papers
AS
Amit Shah
5 papers · 2 as a fellow
Benjamin Movsas
5 papers
Christopher Crane
5 papers

Grants

Universiity of Rochester Center for Medical Countermeasures Against Radiation
National Institute of Allergy and Infectious Diseases · U19
Project lead · $1M · University of Rochester
2010–2016
Rapid Assessment of Radiation Exposure
National Institute of Allergy and Infectious Diseases · R43
PI · $481.6K · Litron Laboratories, Ltd.
2012–2015
Rapid Radiation Dose Estimation
National Institute of Allergy and Infectious Diseases · R43
PI · $600K · Litron Laboratories, Ltd.
2010–2012
Center for Biophysical Assessment and Risk Management Following Irradiation
National Institute of Allergy and Infectious Diseases · U19
Project lead · $3.4M · University of Rochester
2005–2010

Clinical trials

A Phase 1 Dose Escalation Study of GC4419 in Combination With Chemoradiation for Squamous Cell Cancer of the Head & Neck
Principal investigator · Completed · Phase 1
Galera Therapeutics, Inc.
2013–2016
Abraxane and RT for Non-Small Cell Lung Cancer (NSCLC)
Principal investigator · Withdrawn · Phase 2
University of Rochester
2008
S0429: Docetaxel, Cetuximab, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer
Principal investigator · Terminated · Phase 1
SWOG Cancer Research Network
2006–2012
Genotoxicity Assessment for Patients Undergoing Radiation Treatment
Principal investigator · Completed
Yuhchyau Chen
2006–2024